| | | Single nucleotide variant (missense variant) | not provided | |
| | | Single nucleotide variant (missense variant) | not specified | |
| | | Single nucleotide variant (missense variant) | Multiple endocrine neoplasia, type 2 +8 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Medullary thyroid carcinoma | |
| | | Single nucleotide variant (missense variant) | not provided +4 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | Hirschsprung disease, susceptibility to, 1 +12 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | not provided +5 more | |
| | | Single nucleotide variant (missense variant) | Multiple endocrine neoplasia, type 2 | |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +1 more | |
| | | Single nucleotide variant (missense variant) | Multiple endocrine neoplasia, type 2 +1 more | |
| | | Single nucleotide variant (missense variant) | Multiple endocrine neoplasia type 2B | |
| | | Single nucleotide variant (missense variant) | not provided +11 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | not provided | |
| | | Single nucleotide variant (missense variant) | Focal segmental glomerulosclerosis 5 +1 more | |
| | | Single nucleotide variant (missense variant) | not provided | |
| | HSALR1, PIEZO1 (V318M +1 more) | Single nucleotide variant (missense variant) | PIEZO1-related disorder | |
| | | Single nucleotide variant (missense variant +2 more) | Gastric adenocarcinoma +2 more | |
| | | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 1 +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | BRIP1-related disorder +5 more | |